// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























3340 Abstracts

Long-term follow-up of three male siblings with a novel NNT pathogenic variant causing primary adrenal insufficiency

Primoz Kotnik - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Hydrocortisone

Variegated Mosaic Aneuploidy Syndrome In Two Severely Undersized Siblings

- European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

hGH

Variability of the Noonan syndrome phenotypic spectrum in four patients carrying novel LZTR1 gene variants

Alice Meneghin - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Heart muscle disease

hGH

The first case of pediatric Cushing disease in Serbia

Sanja Panić Zarić - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

Aminophylline Injection

Ultrasound-guided serratus anterior plane block (US-SAP block) and ultrasound-guided parasternal block (US-PsB) for s-ICD implantation in severe dilated post-ischaemic cardiomyopathy: a case study

F Marrone - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Dexmedetomidine hydrochloride

When general anesthesia isn’t plan a – case report in a patient with idiopathic cardiomyopathy

S Baptista - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Ropivacaine

Regional anesthesia role during limitation of life sustaining measures – a case report

A Correia - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

INH INDUCED LACTIC ACIDOSIS IN HEMODIALYSIS PATIENT NOT COMPLIANT WITH HEMODIALYSIS AND PYRIDOXIN

N. BASHIR - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Heart muscle disease

Pyrazinamide

MONOCLONAL GAMMOPATHY PRESENTING AS ACUTE PSEUDOHYPERPHOSPHATEMIA IN A MAINTENANCE HEMODIALYSIS PATIENT: A RARE PRESENTATION

V. Martinez - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

cholecalciferol

Flash Pulmonary Edema After Status Epilepticus Reveals Takotsubo’s Cardiomyopathy: Considerations for Intensive Monitoring Post Grand Mal Seizure

L. Sakr - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Endobronchial Valve Treatment for Native Lung Hyperinflation in a Single-Lung Transplant Patient

J. J. Amja - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Heart muscle disease

N/A

Symptomatic Pulmonary Vein Stenosis After Catheter Ablation for Paroxysmal Atrial Fibrillation: A Case Report

A. Mehta - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Can't Find It? Endobronchial Ultrasound (EBUS) Can!: Hilar Lymph Node Evidence of Cardiac Sarcoidosis

F. J. Marquez - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Heart muscle disease

Mycophenolic acid

Anabolic Androgenic Steroid-Induced Cardiomyopathy and Cardiogenic Shock

J. Yabut - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Heart muscle disease

Diltiazem

A Rare Case of Buffalo Chest in a Young Woman

H. Channa - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Dobutamine

Multiorgan Failure in Systemic Lupus Erythematous: The Use of Eculizumab in a Patient with Cardiomyopathy, Acute Kidney Injury, and Pancytopenia

P. E. Dormish - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Heart muscle disease

Mycophenolate mofetil

A Case of Allergic Bronchopulmonary Aspergillosis with Infiltrating Eosinophilic Cardiomyopathy

N. Randhawa - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Prednisone

Hemophagocytic Lymphohistiocytosis-Associated Stress Cardiomyopathy

J. Yabut - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Heart muscle disease

Dexamethasone

A Rare Case of Recurrent Chylothorax from Superior Vena Cava Stenosis

A. Korzhuk - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Cardiogenic Shock Secondary to Stress Induced Cardiomyopathy Precipitated by Severe Diabetic Ketoacidosis

R. A. Gurreri - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

sodium bicarbonate

Copyright © 2026. QuantiNova All rights reserved